Concepedia

Author

Kota Itahashi

National Cancer Center Hospital EastORCID

Also Known As

K. Itahashi, Kota Itahashi

56

Publications

2.2K

Citations

12

H-Index

14

Concepts

All Affiliations

National Cancer Center Hospital EastNagoya UniversityThe University of OsakaTokyo National HospitalChiba Cancer Center
KI

About

Kota Itahashi is an author at National Cancer Center Hospital East specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

1.5K

2

Cell Biology

2

2

1.5K

3

Immunology

2

2

1.5K

4

Autoimmune Disease

1

1

785

5

Autoimmunity

1

1

785

Kota Itahashi

×

10

Publications

2K

Citations

10

H-Index

YearCitations

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai, Yosuke Togashi, Takahiro Kamada,

Nature Immunology

2020

785

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai, Shohei Koyama, Kota Itahashi,

Cancer Cell

2022

752

Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape

Yoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato,

Science Immunology

2021

124

BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors

Kota Itahashi, Takuma Irie, Junichiro Yuda,

Science Immunology

2022

94

TAS-116 (Pimitespib), an Oral HSP90 Inhibitor, in Combination with Nivolumab in Patients with Colorectal Cancer and Other Solid Tumors: An Open-Label, Dose-Finding, and Expansion Phase Ib Trial (EPOC1704)

Akihito Kawazoe, Kota Itahashi, Noboru Yamamoto,

Clinical Cancer Research

2021

64

Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab

Yuka Maeda, Hisashi Wada, Daisuke Sugiyama,

Nature Communications

2021

48

Microbiota-driven antitumour immunity mediated by dendritic cell migration

Yi-Tzu Lin, Shota Fukuoka, Shohei Koyama,

Nature

2025

28

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics

Kota Itahashi, Shunsuke Kondo, Takashi Kubo,

Frontiers in Medicine

2018

25

Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with <i><scp>ABCB</scp>1</i> polymorphism

Yutaka Fujiwara, Akinobu Hamada, Hidenori Mizugaki,

Cancer Science

2016

19

Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non–Small-Cell Lung Cancer: A Retrospective Analysis

Tetsuhiko Asao, Yutaka Fujiwara, Kota Itahashi,

Clinical Lung Cancer

2016

18

Page 1